Could a diabetes drug help fight sarcoma? new trial explores metformin's potential

NCT ID NCT07291297

Recruiting now Disease control Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study looks at whether adding metformin, a common diabetes medicine, to standard cancer treatment can help people with advanced soft tissue sarcoma live longer. About 50 adults whose cancer has spread or cannot be removed will take metformin along with their usual therapy. The main goal is to see how many are still alive after 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOMA METASTATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOMA METASTATIC SARCOMA,SOFT TISSUE

Contacts and locations

Locations

Atrium Health Wake Forest Baptist Comprehensive Cancer Center
RECRUITING

Winston-Salem, North Carolina, 27103, United States
Levine Cancer Institute
RECRUITING

Charlotte, North Carolina, 28204, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.